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Phenylhydrazine is a hemolytic agent whose mechanism of action is related with the formation of free radi- 
cals and the induction of lipid peroxidation. The flavonoid silybin dihemisuccinate is an antihepatotoxic 
principle used in the treatment ofmany liver diseases; its mechanism of action has been ascribed to its anti- 
oxidant properties. This work demonstrates, using a hemoglobin-free perfusion system, the protective effect 
of the in vivo treatment of the rat with silybin dihemisuccinate on the hepatic glutathione depletion and 
lipid peroxidation induced by the infusion of phenylhydrazine into the perfusion buffer. 
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1. INTRODUCTION 
Hydrazine derivatives are widely used in in- 
dustry as fuels, pesticides and explosives as well as 
in medicine in the treatment of tuberculosis and 
hypertension. However, despite their industrial 
and therapeutic use, hydrazines are toxic and can 
cause irreversible cellular damage [ 11. Hydrazines 
are formed during the hepatic metabolism of 
several therapeutic agents such as phenelzine, 
isoniazid, iproniazid and mebanazine [2,3]. 
Phenylhydrazine has long been known as a 
hemolytic agent [4] and was used in the past as a 
therapeutic agent in the treatment of polycythemia 
Vera. The mechanism of action of this hydrazine 
has been extensively studied [5,6]. The interaction 
of phenylhydrazine with hemoglobin generates 
hydrogen peroxide and destroys the pigment 
through the formation of oxidized derivatives and 
free radicals of the hydrazine [7]. Phenylhydrazine 
is capable of inhibiting the function of liver 
microsomal cytochrome P-450 through the forma- 
tion of phenyldiazene free radicals [8]. The same 
intermediates have been demonstrated in the 
microsomal metabolism of isopropylhydrazine 
(the metabolite of iproniazid) and acetylhydrazine 
(the metabolite of isoniazid) where a covalent 
binding of its metabolites to the microsomal pro- 
tein is produced [2]. The formation of free radicals 
during the microsomal oxidation of hydrazines 
leads to the hypothesis that such free radicals are 
involved in the hepatotoxicity of hydrazine deriva- 
tives [9]. 
Silybin dihemisuccinate is a water-soluble form 
of one of the structural isomers of the flavonoid 
silymarin extracted from the milk thistle Silybum 
marianum [lo]. Silybin dihemisuccinate and 
silymarin have been proved to be effective protec- 
tive agents against the hepatotoxicity of 
phalloidin, cu-amanitin, praseodymium, carbon 
tetrachloride and ethionine [ 111. Although the pro- 
tective mechanism of silymarin (and silybin) has 
not been elucidated, it is generally accepted that 
the flavonoid exerts a membrane-stabilizing action 
preventing or inhibiting lipid peroxidation [ 12). 
Recently it has been demonstrated that silymarin 
can prevent the liver glutathione (GSH) depletion 
and lipid peroxidation induced by an acute intox- 
ication with ethanol in the rat [13]. GSH is con- 
sidered the most important biomolecule against 
chemically induced cytotoxicity [ 141. 
This study was undertaken to investigate the ef- 
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feet of a single intraperitoneal dose of silybin 
dihemisuccinate on the hepatic toxicity of 
phenylhydrazine using a hemoglobin-free perfu- 
sion system. The effect of the flavonoid was as- 
sessed by the determination of lipid peroxidation 
of the liver and of the perfusate, by the oxygen 
consumption of the liver and the levels of reduced 
and oxidized hepatic glutathione (GSH and 
GSSG). 
2. EXPERIMENTAL 
Male Wistar rats (Instituto de Nutricibn y Tec- 
nologia de 10s Alimentos) weighing ZOO-250 g 
were injected intraperitoneally with silybin 
dihemisuccinate (50 mg/kg). Controls received on- 
ly saline. Animals were fed with a standard 
laboratory chow and water ad libitum and after 
16 h of treatment were anesthetized prior to 
surgery with sodium pentobarbital (10 mg/lOO g 
body wt). Livers were perfused in situ employing a 
hemoglobin-free nonrecirculating perfusion sys- 
tem and a flow rate of 30 ml. min- ‘. The perfusion 
medium was a Krebs-Henseleit bicarbonate buffer 
[IS] (pH 7.4) saturated with a mixture of oxygen- 
carbon dioxide (95% : 0.5%) maintained at 37°C. 
Phenylhydrazine was infused into the perfusion 
system as indicated by the horizontal bars in the 
figures. Oxygen consumption was monitored with 
a Clark type oxygen electrode placed immediately 
following the liver in the perfusion system and 
recorded with a YSI monitor. Lipid peroxidation 
of the liver and of the perfusate was assessed by 
evaluation of the malondialdehyde thiobarbituric 
complex (MDA) according to Wilbur et al. [16]. 
MDA concentration was expressed as pmol MDA/ 
ml perfusate or nmol MDA/g hepatic protein 
usingan~valueof 1.56x lo3 l~mol-‘-cm-L.The 
determination of GSH and GSSG was carried out 
enzymatically according to Bernt and Bergmeyer 
[17]. This technique was applied to supernatant 
fractions from 2% (w/v) liver homogenates as in 
[18]. Proteins were measured according to Lowry 
et al. 1191. Silybin dihemisu~cinate was a gift from 
Dr Madaus and Co. (FRG). Phenylhydrazine and 
other chemicals were obtained from Sigma (St. 
Louis, USA). Results are expressed as means + SE 
and the significance of the differences between 
mean values was assessed by Student’s r-test for 
unpaired results. 
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3. RESULTS AND DISCUSSION 
3.1. Effect of ph~ny~h_vdrazine pervasion on 
oxygen consumption and malondialdehyde 
release of the liver 
The infusion of phenylhydrazine (2.5 mM) into 
the perfusate resulted in a rapid increase in oxygen 
consumption of the liver from control animals 
(fig.lA). As can be observed in this figure, high 
rates of oxygen consumption, in a period over 
10 min, are produced even when the infusion of 
the hydrazine was stopped. Livers from animals 
treated with silybin dihemisuccinate respond with a 
rather low increase in oxygen consumption, which 
decreases and returns to basal values during the 
final 10 min of phenylhydrazine perfusion. 
MDA release of the liver from control animals 
(fig. 1B) increases 5 or 6 min after phenylhydrazine 
perfusion was initiated, reaching high values which 
are maintained after suspension of the hydrazine 
intoxication. Livers from rats treated with the 
flavonoid evidence only a slight increase in MDA 
values of the perfusate compared with those ob- 
tained from liver not perfused with phenylhy- 
drazine. 
Fig. 1. Effect of phenylhydrazine perfusion on oxygen 
consumption (A) and MDA release (B) of the liver from 
rats treated with silybin dihemisuccinate (50 mglkg 
body wt), The liver was infused for 30 min with 
phenylhydrazine (2.5 mM) as indicated by the horizontal 
bar. Fractions of 2.5 ml of the perfusate were collected 
for MDA determination. Each point represents the mean 
of 5 experiments. Other conditions are described in 
section 2. 
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3.2. Time course of malondialdehyde formation 
during perfusion of the liver with 
phenylhydrazine 
The MDA content of the liver increases after the 
infusion of phenylhydrazine into the perfusion 
buffer (fig.2) concomitantly with the rise in the ox- 
ygen consumption (fig.1). Livers obtained from 
untreated animals show a net increase in MDA 
values. However, livers obtained from rats treated 
with the flavonoid respond with a low increase in 
MDA formation which declines when the 
hydrazine infusion is concluded. The low MDA 
release into the perfusate observed in those livers 
may reflect the capacity of the organ to metabolize 
the lipid peroxidative products. This is not the case 
for livers from untreated animals where high MDA 
production is accompanied by high MDA values in 
the perfusate. 
3.3. Effect of phenylhydrazine perfusion on the 
glutathione content of the liver 
The increase in oxygen consumption and MDA 
formation in control livers may be a consequence 
of uncontrolled lipid peroxidation induced by 
phenylhydrazine. These effects are accompanied 
by a 42% depletion of the GSH and total 
glutathione (GSHr) of the liver after hydrazine 
perfusion (fig.3C) compared with the values ob- 
PNENlL”“OBlZlNE P5 aH 
I I 1 
0 IO 20 30 40 50 60 
PERFUSION TIME (ml” ) 
Fig.2. Time course of hepatic malondialdehyde 
formation after phenylhydrazine p rfusion of the liver 
from rats treated with silybin dihemisuccinate 
(50 mg/kg body wt). The liver was infused for 30 min 
with phenylhydrazine (2.5 mM) as indicated by the 
horizontal bar. The shaded zone corresponds to the 
basal values of MDA obtained from the liver of 
untreated animals. Each point represents the mean of 4 
experiments + SE. Other conditions are described in 
section 2. 
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Fig.3. Effect of phenylhydrazine (2.5 mM) perfusion on 
glutathione levels of the liver from rats treated with 
silybin dihemisuccinate (50 mg/kg body wt). Data 
represent the mean f SE for 8 animals. Total GSH 
equivalents (GSHr) were calculated according to the 
relation GSHr = GSH + 2GSSG. Significance studies: 
GSH = A vs B vs C @ < 0.005); A vs D (N.S.); B vs C 
@ < 0.005); B vs D (p < 0.05). GSSG = A vs B and D 
(N.S.); A vs C @ < 0.005); B vs C @ < 0.05); B vs D 
(N.S.). GSHr = A vs B vs C 0, < 0.005); A vs D (N.S.); 
B vs C @ < 0.005); B vs D (N.S.). N.S., not significant. 
tained before perfusion (fig.3A). The increase in 
GSSG content observed after phenylhydrazine 
treatment may be interpreted as being the result of 
oxidative stress imposed by phenylhydrazine on 
the liver. However, the net decrease in total 
glutathione values indicates release of the tripep- 
tide from the liver into the perfusate (as GSH 
and/or GSSG) which may be a consequence of the 
structural and functional damage produced by the 
hydrazine or its metabolites (as the phenyldiazene 
free radical) [B]. 
Livers from animals treated with the flavonoid 
show an increase in the content of GSH and total 
glutathione (fig.3B) before phenylhydrazine perfu- 
sion compared with control animals (fig.3A). The 
mechanism of the increase in liver glutathione after 
silybin dihemisuccinate or silymarin [ 131 treatment 
is still unknown and is currently being studied. 
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Phenylhydrazine perfusion produces a decrease in 
glutathione content of the liver from rats treated 
with the flavonoid (fig.2D). However, due to the 
high values of this parameter observed before per- 
fusion with the hydrazine, the glutathione status of 
these livers after perfusion resembles control 
values before intoxication. 
It has been proposed that the increase in liver 
glutathione content obtained after silymarin 1131 
or silybin dihemisuccinate treatment would afford 
a better protection of the tissue against an ox- 
idative stress. The low increase in oxygen con- 
sumption, MDA formation and MDA release into 
the perfusate observed in the hver from rats treated 
with the flavonoid may be the result of an in- 
creased b~odisposability of the tripeptide. GSH 
would be utilized in the liver principally as a con- 
jugation agent, a cofactor of the enzyme 
glutathione peroxidase in the metabolism of 
organic peroxides and as a direct free radical 
scavenger [14]. This latter role of GSH would be 
reinforced by the antioxidant properties of silybin 
dihemisuccinate which, acting as a free radical 
scavenger, may inhibit or suppress lipid peroxida- 
tion induced by the hydrazine. This protective ef- 
fect of silybin dihemisuccinate may extend to other 
xenobiotics whose hepatotoxicity is related with 
glutathione depletion and/or lipid peroxidation. 
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